Affliction Grim Reaper and former PRIDE star Josh Barnett has applied for -- and received -- a second extension for his appeal directed towards the ruling of the California State Athletic Commission (CSAC) after he was popped for steroids in a random drug test prior to his August 1 bout against Fedor Emelianenko, according to Sherdog.com.
"The Babyface Assassin" returned a positive "B" sample on July 31, all but confirming his initial test result that began a downward spiral for his employer and fellow fighters.
Barnett’s positive test led to Affliction MMA’s house of cards to come crashing down, calling it quits as a fight promoter and returning to the UFC as a corporate sponsor with its clothing brand. Several intriguing fights were scrapped as a result, forcing fighters to search for work elsewhere … Barnett included.
The former UFC Heavyweight champion issued a press release last month, calling into question the integrity of those results alleged by the CSAC — who does have a fairly sordid history dating back to the Sean Sherk scandal and beyond.
From his official press release:
Mr. Barnett was shocked at these allegations and was extremely disappointed to learn that Affliction had made the hasty decision to cancel the August 1st event in its entirety. Mr. Barnett vehemently denies intentionally ingesting any banned substances in preparation for the August 1st fight and he is looking forward to presenting his case to the California State Athletic Commission.
Barnett is appealing this most recent steroid finding with the CSAC but was likely counting on his second "B" sample to help dispute the initial positive result.
In light of this new development, Barnett will not be eligible to reapply for a license to fight in the United States for at least a year, forcing him to remain exiled in Japan until then. With a FieLDS Dynamite!! card looming and a successful wrestling career; however, it may not be too difficult to find work.
Keep in locked on MMAmania.com as we’ll let you know more on Barnett’s future when it’s announced.